The restructuring involved a common stock consolidation that took effect Nov. 24, 2010. The stock symbol for Solos will be changed temporarily to SNDYD for a period of 20 business days following the consolidation.
The plan will allow Solos greater flexibility to use the assets of the company for corporate purposes, including raising capital, acquisitions or employee compensation.
Read the Solos Endoscopy news release on capital restructuring.
Read more on GI and endoscopy:
–4 Steps to Increase Screening Colonoscopy Cases
–Researchers Revisit Surveillance Colonoscopy Utilization
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.